Paclitaxel LNP Formulation
Cancer (e.g., Breast Cancer)
PreclinicalActive
Key Facts
About Adeira Pharma
Adeira Pharma is a private, preclinical biotech leveraging a versatile targeted nanoparticle platform to overcome historical drug formulation challenges. Its core technology enables the encapsulation or surface attachment of diverse therapeutic payloads, aiming to enhance pharmacokinetics, reduce toxicity, and improve targeted delivery. The company is currently seeking development partners for its lead reformulation candidates, primarily in oncology, and operates a partnership-focused business model without disclosed revenue.
View full company profile